Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02374541 · ClinicalTrials.gov registry record · NA
Screening and Linkage to Services for Autism
A NA study of Autism Spectrum Disorders, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 305
- Enrollment target
- 3
- Study locations
NCT02374541: Completed NA study of Autism Spectrum Disorders, sponsored by University of Colorado, Denver.
NCT02374541 is a NA study of Autism Spectrum Disorders that has completed, run by University of Colorado, Denver. The registered enrollment target is 305 participants, above the 153-participant average among 20 other Autism Spectrum Disorders trials with a reported enrollment target (99% higher). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02374541, a NA study of Autism Spectrum Disorders, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 305 participants
- Enrollment target
- 3
- Study locations
Study Summary
The SaLSA (Screening and Linkage to Services for Autism) study will test whether patient navigation can help disadvantaged families obtain earlier diagnosis and treatment for their children who have had a positive screening test for autism spectrum disorder. Half of the families will be offered help from an autism patient navigator. The other half will receive standard care.
Primary Outcome
Indicated developmental evaluation (aka eligibility determination) completed (Yes/No)
Conditions Studied
Interventions
- BEHAVIORAL Patient Navigation
Study Locations (3)
Colorado
- Colorado School of Public Health, University of Colorado Denver - Aurora
- University of Colorado - Aurora
- Denver Health and Hospital Authority - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 305 participants |
| Start Date | 2015-02-16 |
| Est. Completion | 2018-11-21 |
| Phase | NA |
What the finished NCT02374541 record still lists
NCT02374541 is an interventional study that assigns participants to a tested intervention. The registered 305 participants enrollment target is mid-sized for trials with a published cap, above the 153-participant average among 20 other Autism Spectrum Disorders trials with a reported enrollment target (99% higher).
The record links to 1 condition, with Autism Spectrum Disorders appearing as the primary indexed condition, and to 1 intervention - of which Patient Navigation is the first listed.
NCT02374541 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT02374541 about?
NCT02374541 is a clinical study titled "Screening and Linkage to Services for Autism". The SaLSA (Screening and Linkage to Services for Autism) study will test whether patient navigation can help disadvantaged families obtain earlier diagnosis and treatment for their children who have had a positive screening test for autism spectrum disorder. Half of the families will be offered help...
What is the current status of trial NCT02374541?
This trial is currently completed. It is a NA study. The enrollment target is 305 participants. The study started on 2015-02-16. Estimated completion is 2018-11-21.
What conditions does trial NCT02374541 study?
This clinical trial studies the following conditions: Autism Spectrum Disorders.
What interventions are being tested in trial NCT02374541?
The interventions under investigation include: Patient Navigation (BEHAVIORAL).
Who is sponsoring clinical trial NCT02374541?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02374541 being conducted?
This trial has 3 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02374541's enrollment target sits among peer trials
305 3rd of 20 higher than 18 of 20 other Autism Spectrum Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism Spectrum Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Water Competency Intervention in Autism
RECRUITING · NA
-
Project AFECT (Autism Family Empowerment Coaching and Training Program)
ACTIVE NOT RECRUITING · NA
-
Telehealth Coaching for Families of Children With Autism
COMPLETED · NA
-
Virtual Reality Social Cognition Training for Adults With Autism Spectrum Disorders
COMPLETED · NA
-
Pivotal Response Treatment for Children With Autism Spectrum Disorders
COMPLETED · NA
-
An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04107181 · 305 participants · NA
Pilot Study for Speculum Free Cervical Cancer Screening
- NCT05399056 · 305 participants · NA
Improving Participation in Pulmonary Rehabilitation Through Peer Support and Storytelling
- NCT05078970 · 306 participants · NA
Advancing Suicide Intervention Strategies for Teens During High Risk Periods
- NCT05843695 · 306 participants · NA
Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI